Sector ratings Novo Nordisk A/S

Equities

Real-time Estimate Cboe Europe Other stock markets 06:24:06 2025-07-17 EDT			5-day change	1st Jan Change
428.95 ^DKK	-1.07%		-5.83%	-31.27%

07-16	Gerresheimer calls a halt to discussions on potential takeover	RE
07-16	Gerresheimer calls a halt to discussions on potential takeover	RE

Add to a list 0 selected To use this feature you must be a member Log in Sign up	ESG MSCI	Capi.($)
NOVO NORDISK A/S	A	301B
ELI LILLY AND COMPANY	A	709B
JOHNSON & JOHNSON	A	396B
ABBVIE INC.	A	337B
ROCHE HOLDING AG	A	258B
NOVARTIS AG	AA	234B
ASTRAZENECA PLC	AA	218B
MERCK & CO., INC.	A	207B
AMGEN INC.	A	161B
PFIZER, INC.	BBB	140B
GILEAD SCIENCES, INC.	AAA	137B
VERTEX PHARMACEUTICALS INCORPORATED	AA	121B
SANOFI	BBB	118B
BRISTOL-MYERS SQUIBB COMPANY	A	95.99B
GSK PLC	AA	77.37B
CHUGAI PHARMACEUTICAL CO., LTD.	AA	75.92B
JIANGSU HENGRUI MEDICINE CO., LTD.	A	53.11B
TAKEDA PHARMACEUTICAL COMPANY LIMITED	A	46.87B
Average	AA	204.73B
Weighted average by Cap.	AA